KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Royalty Pharma (RPRX) over the last 7 years, with Q3 2025 value amounting to 5.37.

  • Royalty Pharma's Interest Coverage Ratio fell 5142.65% to 5.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 5.49, marking a year-over-year decrease of 2640.84%. This contributed to the annual value of 5.73 for FY2024, which is 2810.39% down from last year.
  • Royalty Pharma's Interest Coverage Ratio amounted to 5.37 in Q3 2025, which was down 5142.65% from 3.06 recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's Interest Coverage Ratio ranged from a high of 19.9 in Q2 2021 and a low of 10.28 during Q4 2022
  • For the 5-year period, Royalty Pharma's Interest Coverage Ratio averaged around 5.86, with its median value being 5.5 (2024).
  • Per our database at Business Quant, Royalty Pharma's Interest Coverage Ratio plummeted by 41473.06% in 2022 and then soared by 59075.96% in 2025.
  • Over the past 5 years, Royalty Pharma's Interest Coverage Ratio (Quarter) stood at 3.27 in 2021, then crashed by 414.73% to 10.28 in 2022, then surged by 226.18% to 12.97 in 2023, then plummeted by 57.61% to 5.5 in 2024, then dropped by 2.34% to 5.37 in 2025.
  • Its Interest Coverage Ratio stands at 5.37 for Q3 2025, versus 3.06 for Q2 2025 and 8.19 for Q1 2025.